These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2572499)

  • 1. Antigen presentation.
    Unanue ER; Cerottini JC
    FASEB J; 1989 Nov; 3(13):2496-502. PubMed ID: 2572499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binary logic of antigen processing and presentation to T cells.
    Yewdell JW; Bennink JR
    Cell; 1990 Jul; 62(2):203-6. PubMed ID: 1695549
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ability of Ia and H-2Kk-bearing membranes to replace the antigen-presenting cell in an H-2Kk allogeneic cytotoxic T cell response.
    Weinberger O; Herrmann SH; Greenstein JL; Mescher MF; Burakoff SJ
    Eur J Immunol; 1985 Oct; 15(10):1013-8. PubMed ID: 2932336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of endogenous tumor antigens to CD4+ T lymphocytes by murine melanoma cells transfected with major histocompatibility complex class II genes.
    Chen PW; Ullrich SE; Ananthaswamy HN
    J Leukoc Biol; 1994 Oct; 56(4):469-74. PubMed ID: 7930943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens.
    Kosugi A; Yoshioka T; Suda T; Sano H; Takahama Y; Fujiwara H; Hamaoka T
    J Leukoc Biol; 1987 Dec; 42(6):632-41. PubMed ID: 2960766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.
    Xiang J; Huang H; Liu Y
    J Immunol; 2005 Jun; 174(12):7497-505. PubMed ID: 15944248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity.
    Toes RE; Schoenberger SP; van der Voort EI; Offringa R; Melief CJ
    Semin Immunol; 1998 Dec; 10(6):443-8. PubMed ID: 9826577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen presentation to cytotoxic T lymphocytes in vivo.
    Bevan MJ
    J Exp Med; 1995 Sep; 182(3):639-41. PubMed ID: 7650475
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunology. The ins and outs of antigen processing and presentation.
    Germain RN
    Nature; 1986 Aug 21-27; 322(6081):687-9. PubMed ID: 3489186
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen-presenting function of the macrophage.
    Unanue ER
    Annu Rev Immunol; 1984; 2():395-428. PubMed ID: 6242349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioned dendritic cells as a temporal bridge between T helper and cytotoxic cells.
    Hall BM; Chen J; Robinson C; He XY; Plain K; Verma N; Hodgkinson ST
    Transplant Proc; 2001; 33(1-2):195-6. PubMed ID: 11266776
    [No Abstract]   [Full Text] [Related]  

  • 16. How T cells see antigen.
    Grey HM; Sette A; Buus S
    Sci Am; 1989 Nov; 261(5):56-64. PubMed ID: 2530628
    [No Abstract]   [Full Text] [Related]  

  • 17. A helper T cell clone produces an antigen-specific molecule (T-ABM) which functions in the induction of suppression.
    Green DR; Chue B; Zheng HG; Ferguson TA; Beaman KD; Flood PM
    J Mol Cell Immunol; 1987; 3(2):95-108. PubMed ID: 2978240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
    Walden P; Nagy ZA; Klein J
    J Mol Cell Immunol; 1986; 2(4):191-7. PubMed ID: 2978228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells.
    Kaiserlian D; Vidal K; Revillard JP
    Eur J Immunol; 1989 Aug; 19(8):1513-6. PubMed ID: 2570703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.